David Anthony BARDA,David Andrew COATES,Ryan James LINDER,Sheng-Bin PENG,Mohammad Sadegh ZIA-EBRAHIMI
申请号：
US16595666
公开号：
US20200115375A1
申请日:
2019.10.08
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides compounds of the Formula I belowwhere R1, R2 and m are as described herein, pharmaceutically acceptable salts of the compounds of Formula 1, and methods of using these compounds and salts for treating patients for cancer.
